secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001213900-24-039644
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CERO Therapeutics receives Nasdaq deficiency notice for MVLS below $50M; 180-day cure period
--------------------------------------------------------------------------------

- May 2, 2024 Nasdaq letter: CERO's common stock MVLS below $50M for 30 consecutive days.
- Company has until Oct 29, 2024 to regain compliance by closing at MVLS >= $50M for 10 consecutive days.
- If non-compliant, may transfer to Nasdaq Capital Market or face delisting proceedings.
- Company says it will monitor MVLS and evaluate options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024039644/0001213900-24-039644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024039644/ea0205239-8k_cerotherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-039644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer